Contact DMCA Privacy

Robuta

https://pubmed.ncbi.nlm.nih.gov/30192303/?dopt=Abstract
The BET-bromodomain inhibitor JQ1 mitigates vemurafenib drug resistance in melanoma
Inhibition of BRAF improves therapeutic efficacy of BRAF-mutant melanoma. However, drug resistance to BRAF inhibitor is inevitable, and the drug resistance...
the betbromodomain inhibitordrug resistancemitigatesvemurafenib